MRSA Research - Methicillin-Resistant Staphylococcus Aureus, Hospitals, Infection, Antibiotic Resistance, Superbugs

MRSA Research Today is a free monthly online journal that collates and summarizes the latest research about MRSA, including details on methicillin-resistant staphylococcus aureus, hospitals, infection, antibiotic resistance, superbugs.


MRSA Research Today

Home

View Latest Issue

Information About MRSA

Books on MRSA

Advertising in Research Today

View Other Research Today Publications



Volume 8 (2011), Issue 2 (February)

  1. Subinhibitory Concentrations of Perilla Oil Affect the Expression of Secreted Virulence Factor Genes in Staphylococcus aureus.
    PLoS One, 6(1): e16160. [Abstract] [Full-text]
  2. An Unexpected Location of the Arginine Catabolic Mobile Element (ACME) in a USA300-Related MRSA Strain.
    PLoS One, 6(1): e16193. [Abstract] [Full-text]
  3. Vancomycin Bactericidal Activity as a predictor of 30-day mortality in Methicillin-Resistant Staphylococcus aureus Bacteremia.
    Antimicrob Agents Chemother. [Abstract] [Full-text]
  4. Chitosan Augments Photodynamic Inactivation of Gram-Positive and Gram-Negative Bacteria.
    Antimicrob Agents Chemother. [Abstract] [Full-text]
  5. In vivo efficacy of the next-generation aminoglycoside ACHN-490 in murine infection models.
    Antimicrob Agents Chemother. [Abstract] [Full-text]
  6. Mupirocin resistance in Staphylococcus aureus causing recurrent skin and soft tissue infections in children.
    Antimicrob Agents Chemother. [Abstract] [Full-text]
  7. An investigation of bacterial contamination on treatment table surfaces of chiropractors in private practice and attitudes and practices concerning table disinfection.
    Am J Infect Control, 39(1): 56-63. [Abstract] [Full-text]
  8. Prevalence of and risk factors for methicillin-resistant Staphylococcus aureus colonization and infection among infants at a level III neonatal intensive care unit.
    Am J Infect Control, 39(1): 35-41. [Abstract] [Full-text]
  9. Cost of screening intensive care unit patients for methicillin-resistant Staphylococcus aureus in hospitals.
    Am J Infect Control, 39(1): 27-34. [Abstract] [Full-text]
  10. Antimicrobial activity and mechanism of action of Nu-3, a protonated modified nucleotide.
    Ann Clin Microbiol Antimicrob, 10(1): 1. [Abstract] [Full-text]
  11. Molecular Epidemiology of Methicillin-Resistant and Methicillin-Susceptible Staphylococcus aureus Isolated from the Eye.
    Curr Eye Res, 36(2): 94-102. [Abstract] [Full-text]
  12. Outcomes and management costs in patients hospitalized for skin and skin-structure infections.
    Am J Infect Control, 39(1): 42-9. [Abstract] [Full-text]
  13. Subinhibitory Concentrations of Perilla Oil Affect the Expression of Secreted Virulence Factor Genes in Staphylococcus aureus.
    PLoS One, 6(1): e16160. [Abstract] [Full-text]
  14. An Unexpected Location of the Arginine Catabolic Mobile Element (ACME) in a USA300-Related MRSA Strain.
    PLoS One, 6(1): e16193. [Abstract] [Full-text]
  15. Vancomycin Bactericidal Activity as a predictor of 30-day mortality in Methicillin-Resistant Staphylococcus aureus Bacteremia.
    Antimicrob Agents Chemother. [Abstract] [Full-text]
  16. Chitosan Augments Photodynamic Inactivation of Gram-Positive and Gram-Negative Bacteria.
    Antimicrob Agents Chemother. [Abstract] [Full-text]
  17. In vivo efficacy of the next-generation aminoglycoside ACHN-490 in murine infection models.
    Antimicrob Agents Chemother. [Abstract] [Full-text]
  18. Mupirocin resistance in Staphylococcus aureus causing recurrent skin and soft tissue infections in children.
    Antimicrob Agents Chemother. [Abstract] [Full-text]
  19. An investigation of bacterial contamination on treatment table surfaces of chiropractors in private practice and attitudes and practices concerning table disinfection.
    Am J Infect Control, 39(1): 56-63. [Abstract] [Full-text]
  20. Prevalence of and risk factors for methicillin-resistant Staphylococcus aureus colonization and infection among infants at a level III neonatal intensive care unit.
    Am J Infect Control, 39(1): 35-41. [Abstract] [Full-text]
  21. Cost of screening intensive care unit patients for methicillin-resistant Staphylococcus aureus in hospitals.
    Am J Infect Control, 39(1): 27-34. [Abstract] [Full-text]
  22. Antimicrobial activity and mechanism of action of Nu-3, a protonated modified nucleotide.
    Ann Clin Microbiol Antimicrob, 10(1): 1. [Abstract] [Full-text]
  23. Molecular Epidemiology of Methicillin-Resistant and Methicillin-Susceptible Staphylococcus aureus Isolated from the Eye.
    Curr Eye Res, 36(2): 94-102. [Abstract] [Full-text]
  24. Outcomes and management costs in patients hospitalized for skin and skin-structure infections.
    Am J Infect Control, 39(1): 42-9. [Abstract] [Full-text]
  25. An unexpected location of the arginine catabolic mobile element (ACME) in a USA300-related MRSA strain.
    PLoS One, 6(1): e16193. [Abstract] [Full-text]
  26. Vancomycin Bactericidal Activity as a predictor of 30-day mortality in Methicillin-Resistant Staphylococcus aureus Bacteremia.
    Antimicrob Agents Chemother. [Abstract] [Full-text]
  27. Chitosan Augments Photodynamic Inactivation of Gram-Positive and Gram-Negative Bacteria.
    Antimicrob Agents Chemother. [Abstract] [Full-text]
  28. In vivo efficacy of the next-generation aminoglycoside ACHN-490 in murine infection models.
    Antimicrob Agents Chemother. [Abstract] [Full-text]
  29. Mupirocin resistance in Staphylococcus aureus causing recurrent skin and soft tissue infections in children.
    Antimicrob Agents Chemother. [Abstract] [Full-text]
  30. An investigation of bacterial contamination on treatment table surfaces of chiropractors in private practice and attitudes and practices concerning table disinfection.
    Am J Infect Control, 39(1): 56-63. [Abstract] [Full-text]
  31. Prevalence of and risk factors for methicillin-resistant Staphylococcus aureus colonization and infection among infants at a level III neonatal intensive care unit.
    Am J Infect Control, 39(1): 35-41. [Abstract] [Full-text]
  32. Cost of screening intensive care unit patients for methicillin-resistant Staphylococcus aureus in hospitals.
    Am J Infect Control, 39(1): 27-34. [Abstract] [Full-text]
  33. MRSA--global threat and personal disaster: patients' experiences.
    Int Nurs Rev, 58(1): 47-53. [Abstract] [Full-text]
  34. Molecular epidemiology of methicillin-resistant and methicillin-susceptible Staphylococcus aureus isolated from the eye.
    Curr Eye Res, 36(2): 94-102. [Abstract] [Full-text]
  35. Outcomes and management costs in patients hospitalized for skin and skin-structure infections.
    Am J Infect Control, 39(1): 42-9. [Abstract] [Full-text]
  36. MRSA--global threat and personal disaster: patients' experiences.
    Int Nurs Rev, 58(1): 47-53. [Abstract] [Full-text]
  37. MRSA--global threat and personal disaster: patients' experiences.
    Int Nurs Rev, 58(1): 47-53. [Abstract] [Full-text]
  38. Nosocomial infections and multidrug-resistant bacterial organisms in the pediatric intensive care unit.
    Indian J Pediatr, 78(2): 176-84. [Abstract] [Full-text]
  39. Nosocomial infections and multidrug-resistant bacterial organisms in the pediatric intensive care unit.
    Indian J Pediatr, 78(2): 176-84. [Abstract] [Full-text]
  40. Nosocomial infections and multidrug-resistant bacterial organisms in the pediatric intensive care unit.
    Indian J Pediatr, 78(2): 176-84. [Abstract] [Full-text]
  41. Evaluation of three swab transport systems for the maintenance of clinically important bacteria in simulated mono- and polymicrobial samples.
    APMIS, 119(3): 198-203. [Abstract] [Full-text]
  42. Evaluation of three swab transport systems for the maintenance of clinically important bacteria in simulated mono- and polymicrobial samples.
    APMIS, 119(3): 198-203. [Abstract] [Full-text]
  43. Ag-doped 45S5 Bioglass(®)-based bone scaffolds by molten salt ion exchange: processing and characterisation.
    J Mater Sci Mater Med. [Abstract] [Full-text]
  44. Emergence of Community-Associated Methicillin-Resistant Staphylococcus aureus Carriage in Children in Cambodia.
    Am J Trop Med Hyg, 84(2): 313-7. [Abstract] [Full-text]
  45. Detection and characterization of ST97-SCCmecV Community-Associated Methicillin-Resistant Staphylococcus aureus clone in a Neonatal Intensive Care and Special Care Baby Unit.
    J Med Microbiol. [Abstract] [Full-text]
  46. Discovery of torezolid as a novel 5-hydroxymethyl-oxazolidinone antibacterial agent.
    Eur J Med Chem. [Abstract] [Full-text]
  47. Should healthcare workers be screened routinely for meticillin-resistant Staphylococcus aureus? A review of the evidence.
    J Hosp Infect. [Abstract] [Full-text]
  48. Ag-doped 45S5 Bioglass(®)-based bone scaffolds by molten salt ion exchange: processing and characterisation.
    J Mater Sci Mater Med. [Abstract] [Full-text]
  49. Emergence of Community-Associated Methicillin-Resistant Staphylococcus aureus Carriage in Children in Cambodia.
    Am J Trop Med Hyg, 84(2): 313-7. [Abstract] [Full-text]
  50. Detection and characterization of ST97-SCCmecV Community-Associated Methicillin-Resistant Staphylococcus aureus clone in a Neonatal Intensive Care and Special Care Baby Unit.
    J Med Microbiol. [Abstract] [Full-text]
  51. Discovery of torezolid as a novel 5-hydroxymethyl-oxazolidinone antibacterial agent.
    Eur J Med Chem. [Abstract] [Full-text]
  52. Should healthcare workers be screened routinely for meticillin-resistant Staphylococcus aureus? A review of the evidence.
    J Hosp Infect. [Abstract] [Full-text]
  53. Ag-doped 45S5 Bioglass(®)-based bone scaffolds by molten salt ion exchange: processing and characterisation.
    J Mater Sci Mater Med. [Abstract] [Full-text]
  54. Emergence of community-associated methicillin-resistant staphylococcus aureus carriage in children in Cambodia.
    Am J Trop Med Hyg, 84(2): 313-7. [Abstract] [Full-text]
  55. Detection and characterization of ST97-SCCmecV Community-Associated Methicillin-Resistant Staphylococcus aureus clone in a Neonatal Intensive Care and Special Care Baby Unit.
    J Med Microbiol. [Abstract] [Full-text]
  56. Conceptual model for reducing infections and antimicrobial resistance in skilled nursing facilities: focusing on residents with indwelling devices.
    Clin Infect Dis, 52(5): 654-61. [Abstract] [Full-text]
  57. Should healthcare workers be screened routinely for meticillin-resistant Staphylococcus aureus? A review of the evidence.
    J Hosp Infect. [Abstract] [Full-text]
  58. Conceptual model for reducing infections and antimicrobial resistance in skilled nursing facilities: focusing on residents with indwelling devices.
    Clin Infect Dis, 52(5): 654-61. [Abstract] [Full-text]
  59. Conceptual model for reducing infections and antimicrobial resistance in skilled nursing facilities: focusing on residents with indwelling devices.
    Clin Infect Dis, 52(5): 654-61. [Abstract] [Full-text]
  60. Successful management of an MRSA outbreak in a neonatal intensive care unit.
    Eur J Clin Microbiol Infect Dis. [Abstract] [Full-text]
  61. Clinical evaluation of the Copan ESwab for methicillin-resistant Staphylococcus aureus detection and culture of wounds.
    Eur J Clin Microbiol Infect Dis. [Abstract] [Full-text]
  62. Highly Selective End-Tagged Antimicrobial Peptides Derived from PRELP.
    PLoS One, 6(1): e16400. [Abstract] [Full-text]
  63. In vitro electrophysiological investigations of the acute effects of linezolid and novel oxazolidinones on central nervous system neurons.
    Neuroscience. [Abstract] [Full-text]
  64. In vitro antibacterial activity of ceftobiprole against clinical isolates from French teaching hospitals: proposition of zone diameter breakpoints.
    Int J Antimicrob Agents. [Abstract] [Full-text]
  65. The prevention of biofilm colonization by multidrug-resistant pathogens that cause ventilator-associated pneumonia with antimicrobial-coated endotracheal tubes.
    Biomaterials. [Abstract] [Full-text]
  66. A new experimental model of acute osteomyelitis due to methicillin-resistant Staphylococcus aureus in rabbit.
    Lett Appl Microbiol, 52(3): 253-7. [Abstract] [Full-text]
  67. Orientation and expression of methicillin-resistant Staphylococcus aureus small RNAs by direct multiplexed measurements using the nCounter of NanoString technology.
    J Microbiol Methods, 84(2): 327-34. [Abstract] [Full-text]
  68. Loop-mediated isothermal amplification assays for identification of antiseptic- and methicillin-resistant Staphylococcus aureus.
    J Microbiol Methods, 84(2): 251-4. [Abstract] [Full-text]
  69. High Proportion of Wrongly Identified Methicillin-Resistant Staphylococcus aureus Carriers by Use of a Rapid Commercial PCR Assay Due to Presence of Staphylococcal Cassette Chromosome Element Lacking the mecA Gene.
    J Clin Microbiol, 49(2): 722-4. [Abstract] [Full-text]
  70. Methicillin-resistant Staphylococcus aureus bacteremia: epidemiology, outcome, and laboratory characteristics in a tertiary referral center in the UK.
    Int J Infect Dis, 15(2): e131-5. [Abstract] [Full-text]
  71. The role of diabetes mellitus in the treatment of skin and skin structure infections caused by methicillin-resistant Staphylococcus aureus: results from three randomized controlled trials.
    Int J Infect Dis, 15(2): e140-6. [Abstract] [Full-text]
  72. Rapid PCR Detection of Staphylococcus aureus Clonal Complex 398 by Targeting the Restriction-Modification System Carrying sau1-hsdS1.
    J Clin Microbiol, 49(2): 732-4. [Abstract] [Full-text]
  73. Distinct Bacteriophages Encoding Panton-Valentine Leukocidin (PVL) among International Methicillin-Resistant Staphylococcus aureus Clones Harboring PVL.
    J Clin Microbiol, 49(2): 684-92. [Abstract] [Full-text]
  74. Risk factors and mortality of nosocomial infections of methicillin-resistant Staphylococcus aureus in an intensive care unit.
    J Crit Care, 26(1): 82-8. [Abstract] [Full-text]
  75. Successful management of an MRSA outbreak in a neonatal intensive care unit.
    Eur J Clin Microbiol Infect Dis. [Abstract] [Full-text]
  76. Clinical evaluation of the Copan ESwab for methicillin-resistant Staphylococcus aureus detection and culture of wounds.
    Eur J Clin Microbiol Infect Dis. [Abstract] [Full-text]
  77. Highly Selective End-Tagged Antimicrobial Peptides Derived from PRELP.
    PLoS One, 6(1): e16400. [Abstract] [Full-text]
  78. A new experimental model of acute osteomyelitis due to methicillin-resistant Staphylococcus aureus in rabbit.
    Lett Appl Microbiol, 52(3): 253-7. [Abstract] [Full-text]
  79. Orientation and expression of methicillin-resistant Staphylococcus aureus small RNAs by direct multiplexed measurements using the nCounter of NanoString technology.
    J Microbiol Methods, 84(2): 327-34. [Abstract] [Full-text]
  80. Loop-mediated isothermal amplification assays for identification of antiseptic- and methicillin-resistant Staphylococcus aureus.
    J Microbiol Methods, 84(2): 251-4. [Abstract] [Full-text]
  81. High Proportion of Wrongly Identified Methicillin-Resistant Staphylococcus aureus Carriers by Use of a Rapid Commercial PCR Assay Due to Presence of Staphylococcal Cassette Chromosome Element Lacking the mecA Gene.
    J Clin Microbiol, 49(2): 722-4. [Abstract] [Full-text]
  82. Methicillin-resistant Staphylococcus aureus bacteremia: epidemiology, outcome, and laboratory characteristics in a tertiary referral center in the UK.
    Int J Infect Dis, 15(2): e131-5. [Abstract] [Full-text]
  83. The role of diabetes mellitus in the treatment of skin and skin structure infections caused by methicillin-resistant Staphylococcus aureus: results from three randomized controlled trials.
    Int J Infect Dis, 15(2): e140-6. [Abstract] [Full-text]
  84. Rapid PCR Detection of Staphylococcus aureus Clonal Complex 398 by Targeting the Restriction-Modification System Carrying sau1-hsdS1.
    J Clin Microbiol, 49(2): 732-4. [Abstract] [Full-text]
  85. Distinct Bacteriophages Encoding Panton-Valentine Leukocidin (PVL) among International Methicillin-Resistant Staphylococcus aureus Clones Harboring PVL.
    J Clin Microbiol, 49(2): 684-92. [Abstract] [Full-text]
  86. Risk factors and mortality of nosocomial infections of methicillin-resistant Staphylococcus aureus in an intensive care unit.
    J Crit Care, 26(1): 82-8. [Abstract] [Full-text]
  87. Successful management of an MRSA outbreak in a neonatal intensive care unit.
    Eur J Clin Microbiol Infect Dis. [Abstract] [Full-text]
  88. Clinical evaluation of the Copan ESwab for methicillin-resistant Staphylococcus aureus detection and culture of wounds.
    Eur J Clin Microbiol Infect Dis. [Abstract] [Full-text]
  89. Highly selective end-tagged antimicrobial peptides derived from PRELP.
    PLoS One, 6(1): e16400. [Abstract] [Full-text]
  90. A new experimental model of acute osteomyelitis due to methicillin-resistant Staphylococcus aureus in rabbit.
    Lett Appl Microbiol, 52(3): 253-7. [Abstract] [Full-text]
  91. Orientation and expression of methicillin-resistant Staphylococcus aureus small RNAs by direct multiplexed measurements using the nCounter of NanoString technology.
    J Microbiol Methods, 84(2): 327-34. [Abstract] [Full-text]
  92. Loop-mediated isothermal amplification assays for identification of antiseptic- and methicillin-resistant Staphylococcus aureus.
    J Microbiol Methods, 84(2): 251-4. [Abstract] [Full-text]
  93. High proportion of wrongly identified methicillin-resistant Staphylococcus aureus carriers by use of a rapid commercial PCR assay due to presence of staphylococcal cassette chromosome element lacking the mecA gene.
    J Clin Microbiol, 49(2): 722-4. [Abstract] [Full-text]
  94. Methicillin-resistant Staphylococcus aureus bacteremia: epidemiology, outcome, and laboratory characteristics in a tertiary referral center in the UK.
    Int J Infect Dis, 15(2): e131-5. [Abstract] [Full-text]
  95. The role of diabetes mellitus in the treatment of skin and skin structure infections caused by methicillin-resistant Staphylococcus aureus: results from three randomized controlled trials.
    Int J Infect Dis, 15(2): e140-6. [Abstract] [Full-text]
  96. Rapid PCR detection of Staphylococcus aureus clonal complex 398 by targeting the restriction-modification system carrying sau1-hsdS1.
    J Clin Microbiol, 49(2): 732-4. [Abstract] [Full-text]
  97. Distinct bacteriophages encoding Panton-Valentine leukocidin (PVL) among international methicillin-resistant Staphylococcus aureus clones harboring PVL.
    J Clin Microbiol, 49(2): 684-92. [Abstract] [Full-text]
  98. Risk factors and mortality of nosocomial infections of methicillin-resistant Staphylococcus aureus in an intensive care unit.
    J Crit Care, 26(1): 82-8. [Abstract] [Full-text]
  99. A new experimental model of acute osteomyelitis due to methicillin-resistant Staphylococcus aureus in rabbit.
    Lett Appl Microbiol, 52(3): 253-7. [Abstract] [Full-text]
  100. A new experimental model of acute osteomyelitis due to methicillin-resistant Staphylococcus aureus in rabbit.
    Lett Appl Microbiol, 52(3): 253-7. [Abstract] [Full-text]
  101. Frequency and risk factors for sepsis resulting from neuroendovascular treatment.
    Minim Invasive Neurosurg, 53(5): 250-4. [Abstract] [Full-text]
  102. Skin and soft-tissue infections in suburban primary care: epidemiology of methicillin-resistant Staphylococcus aureus and observations on abscess management.
    BMC Res Notes, 4(1): 33. [Abstract] [Full-text]
  103. Frequency and risk factors for sepsis resulting from neuroendovascular treatment.
    Minim Invasive Neurosurg, 53(5): 250-4. [Abstract] [Full-text]
  104. Acceleration of the direct identification of Staphylococcus aureus versus coagulase-negative staphylococci from blood culture material: a comparison of six bacterial DNA extraction methods.
    Eur J Clin Microbiol Infect Dis, 30(3): 337-42. [Abstract] [Full-text]
  105. Utility of antimicrobial susceptibility-based algorithms for the presumptive identification of genotypically-defined community-associated methicillin-resistant Staphylococcus aureus at a London teaching hospital.
    Eur J Clin Microbiol Infect Dis, 30(3): 459-63. [Abstract] [Full-text]
  106. Acceleration of the direct identification of Staphylococcus aureus versus coagulase-negative staphylococci from blood culture material: a comparison of six bacterial DNA extraction methods.
    Eur J Clin Microbiol Infect Dis, 30(3): 337-42. [Abstract] [Full-text]
  107. Utility of antimicrobial susceptibility-based algorithms for the presumptive identification of genotypically-defined community-associated methicillin-resistant Staphylococcus aureus at a London teaching hospital.
    Eur J Clin Microbiol Infect Dis, 30(3): 459-63. [Abstract] [Full-text]
  108. Acceleration of the direct identification of Staphylococcus aureus versus coagulase-negative staphylococci from blood culture material: a comparison of six bacterial DNA extraction methods.
    Eur J Clin Microbiol Infect Dis, 30(3): 337-42. [Abstract] [Full-text]
  109. Utility of antimicrobial susceptibility-based algorithms for the presumptive identification of genotypically-defined community-associated methicillin-resistant Staphylococcus aureus at a London teaching hospital.
    Eur J Clin Microbiol Infect Dis, 30(3): 459-63. [Abstract] [Full-text]
  110. Transcription and Translation Products of the Cytolysin Gene psm-mec on the Mobile Genetic Element SCCmec Regulate Staphylococcus aureus Virulence.
    PLoS Pathog, 7(2): e1001267. [Abstract] [Full-text]
  111. Intra-wound Application of Vancomycin for Prophylaxis In Instrumented Thoracolumbar Fusions: Efficacy, Drug Levels, and Patient Outcomes.
    Spine (Phila Pa 1976). [Abstract] [Full-text]
  112. Vulnerability of an equine pericardial roll graft to gram-positive cocci after graft replacement for a ruptured infected abdominal aorta.
    Interact Cardiovasc Thorac Surg. [Abstract] [Full-text]
  113. Transcription and Translation Products of the Cytolysin Gene psm-mec on the Mobile Genetic Element SCCmec Regulate Staphylococcus aureus Virulence.
    PLoS Pathog, 7(2): e1001267. [Abstract] [Full-text]
  114. Intra-wound Application of Vancomycin for Prophylaxis In Instrumented Thoracolumbar Fusions: Efficacy, Drug Levels, and Patient Outcomes.
    Spine (Phila Pa 1976). [Abstract] [Full-text]
  115. Vulnerability of an equine pericardial roll graft to gram-positive cocci after graft replacement for a ruptured infected abdominal aorta.
    Interact Cardiovasc Thorac Surg. [Abstract] [Full-text]
  116. Community-associated methicillin-resistant Staphylococcus aureus infected chronic scalp wound with exposed dura in a 10 year old boy: Vacuum-assisted-closure is a feasible option.
    Neurosurgery. [Abstract] [Full-text]
  117. Comparison of the rep-PCR system DiversiLab with spa typing and pulsed-field gel electrophoresis for the clonal characterization of methicillin-resistant Staphylococcus aureus.
    J Clin Microbiol. [Abstract] [Full-text]
  118. Genotypic and Phenotypic Characterization of Methicillin-Susceptible Staphylococcus aureus Isolates Misidentified as Methicillin-Resistant Staphylococcus aureus by the BD GeneOhmTM MRSA Assay.
    J Clin Microbiol. [Abstract] [Full-text]
  119. Assessment of phytochemical content, polyphenolic composition, antioxidant and antibacterial activities of Leguminosae medicinal plants in Peninsular Malaysia.
    BMC Complement Altern Med, 11(1): 12. [Abstract] [Full-text]
  120. Synergistic activity of 1-(1-naphthylmethyl)-piperazine with ciprofloxacin against clinically resistant Staphylococcus aureus, as determined by different methods.
    Lett Appl Microbiol. [Abstract] [Full-text]
  121. Antimicrobial-susceptible patterns of Staphylococcus aureus isolated from surgical infections: a new approach.
    J Infect Chemother, 17(1): 34-9. [Abstract] [Full-text]
  122. Antibacterial effects of brand-name teicoplanin and generic products against clinical isolates of methicillin-resistant Staphylococcus aureus.
    J Infect Chemother, 17(1): 30-3. [Abstract] [Full-text]
  123. Clinical characteristics of vancomycin minimum inhibitory concentration of 2 μg/ml methicillin-resistant Staphylococcus aureus strains isolated from patients with bacteremia.
    J Infect Chemother, 17(1): 52-7. [Abstract] [Full-text]
  124. Linezolid-resistant Staphylococcus aureus isolated from 2006 through 2008 at six hospitals in Japan.
    J Infect Chemother, 17(1): 45-51. [Abstract] [Full-text]
  125. Community-associated methicillin-resistant Staphylococcus aureus infected chronic scalp wound with exposed dura in a 10 year old boy: Vacuum-assisted-closure is a feasible option.
    Neurosurgery. [Abstract] [Full-text]
  126. Comparison of the rep-PCR system DiversiLab with spa typing and pulsed-field gel electrophoresis for the clonal characterization of methicillin-resistant Staphylococcus aureus.
    J Clin Microbiol. [Abstract] [Full-text]
  127. Genotypic and Phenotypic Characterization of Methicillin-Susceptible Staphylococcus aureus Isolates Misidentified as Methicillin-Resistant Staphylococcus aureus by the BD GeneOhmTM MRSA Assay.
    J Clin Microbiol. [Abstract] [Full-text]
  128. Antimicrobial-susceptible patterns of Staphylococcus aureus isolated from surgical infections: a new approach.
    J Infect Chemother, 17(1): 34-9. [Abstract] [Full-text]
  129. Antibacterial effects of brand-name teicoplanin and generic products against clinical isolates of methicillin-resistant Staphylococcus aureus.
    J Infect Chemother, 17(1): 30-3. [Abstract] [Full-text]
  130. Clinical characteristics of vancomycin minimum inhibitory concentration of 2 μg/ml methicillin-resistant Staphylococcus aureus strains isolated from patients with bacteremia.
    J Infect Chemother, 17(1): 52-7. [Abstract] [Full-text]
  131. Linezolid-resistant Staphylococcus aureus isolated from 2006 through 2008 at six hospitals in Japan.
    J Infect Chemother, 17(1): 45-51. [Abstract] [Full-text]
  132. Surgical treatment for chronic type A aortic dissection and aortic regurgitation in a patient with a tracheostoma.
    Gen Thorac Cardiovasc Surg, 59(2): 110-3. [Abstract] [Full-text]
  133. Newly cleaned physician uniforms and infrequently washed white coats have similar rates of bacterial contamination after an 8-hour workday: A randomized controlled trial.
    J Hosp Med. [Abstract] [Full-text]
  134. Synthesis, conformational analysis and biological properties of a dicarba derivative of the antimicrobial peptide, brevinin-1BYa.
    Eur Biophys J. [Abstract] [Full-text]
  135. The effectiveness of methicillin-resistant Staphylococcus aureus colonisation screening in asymptomatic healthcare workers in an Irish orthopaedic unit.
    Eur J Clin Microbiol Infect Dis. [Abstract] [Full-text]
  136. Staphylococcus aureus bacteraemia at Alice Springs Hospital, Central Australia, 2003-2006.
    Intern Med J. [Abstract] [Full-text]
  137. Newly cleaned physician uniforms and infrequently washed white coats have similar rates of bacterial contamination after an 8-hour workday: A randomized controlled trial.
    J Hosp Med. [Abstract] [Full-text]
  138. Synthesis, conformational analysis and biological properties of a dicarba derivative of the antimicrobial peptide, brevinin-1BYa.
    Eur Biophys J. [Abstract] [Full-text]
  139. The effectiveness of methicillin-resistant Staphylococcus aureus colonisation screening in asymptomatic healthcare workers in an Irish orthopaedic unit.
    Eur J Clin Microbiol Infect Dis. [Abstract] [Full-text]
  140. Staphylococcus aureus bacteraemia at Alice Springs Hospital, Central Australia, 2003-2006.
    Intern Med J. [Abstract] [Full-text]
  141. MRSA as an occupational disease: a case series.
    Int Arch Occup Environ Health, 84(3): 259-66. [Abstract] [Full-text]
  142. Lack of evidence for persistent nasal colonization with community-acquired methicillin-resistant Staphylococcus aureus in a central European cohort.
    Clin Microbiol Infect, 17(3): 466-8. [Abstract] [Full-text]
  143. Trends among pathogens reported as causing bacteraemia in England, 2004-2008.
    Clin Microbiol Infect, 17(3): 451-8. [Abstract] [Full-text]
  144. Clinical impact of a real-time PCR assay for rapid identification of Staphylococcus aureus and determination of methicillin resistance from positive blood cultures.
    Clin Microbiol Infect, 17(3): 425-31. [Abstract] [Full-text]
  145. Newly cleaned physician uniforms and infrequently washed white coats have similar rates of bacterial contamination after an 8-hour workday: A randomized controlled trial.
    J Hosp Med. [Abstract] [Full-text]
  146. Synthesis, conformational analysis and biological properties of a dicarba derivative of the antimicrobial peptide, brevinin-1BYa.
    Eur Biophys J. [Abstract] [Full-text]
  147. The effectiveness of methicillin-resistant Staphylococcus aureus colonisation screening in asymptomatic healthcare workers in an Irish orthopaedic unit.
    Eur J Clin Microbiol Infect Dis. [Abstract] [Full-text]
  148. Staphylococcus aureus bacteraemia at Alice Springs Hospital, Central Australia, 2003-2006.
    Intern Med J. [Abstract] [Full-text]
  149. MRSA as an occupational disease: a case series.
    Int Arch Occup Environ Health, 84(3): 259-66. [Abstract] [Full-text]
  150. Lack of evidence for persistent nasal colonization with community-acquired methicillin-resistant Staphylococcus aureus in a central European cohort.
    Clin Microbiol Infect, 17(3): 466-8. [Abstract] [Full-text]
  151. Trends among pathogens reported as causing bacteraemia in England, 2004-2008.
    Clin Microbiol Infect, 17(3): 451-8. [Abstract] [Full-text]
  152. Clinical impact of a real-time PCR assay for rapid identification of Staphylococcus aureus and determination of methicillin resistance from positive blood cultures.
    Clin Microbiol Infect, 17(3): 425-31. [Abstract] [Full-text]
  153. MRSA as an occupational disease: a case series.
    Int Arch Occup Environ Health, 84(3): 259-66. [Abstract] [Full-text]
  154. Lack of evidence for persistent nasal colonization with community-acquired methicillin-resistant Staphylococcus aureus in a central European cohort.
    Clin Microbiol Infect, 17(3): 466-8. [Abstract] [Full-text]
  155. Trends among pathogens reported as causing bacteraemia in England, 2004-2008.
    Clin Microbiol Infect, 17(3): 451-8. [Abstract] [Full-text]
  156. Clinical impact of a real-time PCR assay for rapid identification of Staphylococcus aureus and determination of methicillin resistance from positive blood cultures.
    Clin Microbiol Infect, 17(3): 425-31. [Abstract] [Full-text]
  157. Clinical features and outcomes of Staphylococcus aureus infections in non-neutropenic cancer patients.
    Support Care Cancer. [Abstract] [Full-text]
  158. Colonization and transmission of methicillin-susceptible and methicillin-resistant Staphylococcus aureus in a murine nasal colonization model.
    J Med Microbiol. [Abstract] [Full-text]
  159. Phellinstatin, a new inhibitor of enoyl-ACP reductase produced by the medicinal fungus Phellinus linteus.
    Bioorg Med Chem Lett. [Abstract] [Full-text]
  160. Bacterial colonization patterns in neonates transferred from neonatal intensive care units.
    Int J Hyg Environ Health. [Abstract] [Full-text]
  161. Angioembolisation of pulmonary artery pseudoaneurysm arising in H1N1 influenza viral pneumonia.
    Heart Lung Circ. [Abstract] [Full-text]
  162. Ketamine inhibits tumor necrosis factor secretion by RAW264.7 murine macrophages stimulated with antibiotic-exposed strains of community-associated, methicillin-resistant Staphylococcus aureus.
    BMC Immunol, 12: 11. [Abstract] [Full-text]
  163. Host Chemokines Bind to Staphylococcus aureus and Stimulate Protein A Release.
    J Biol Chem, 286(7): 5069-77. [Abstract] [Full-text]
  164. Drainage Surgery Followed by Postoperative Irrigation with Gentian Violet for Prosthetic Graft Infection Caused by Methicillin-resistant Staphylococcus aureus.
    Eur J Vasc Endovasc Surg, 41(2): 278-80. [Abstract] [Full-text]
  165. Phylogenetic analysis and antimicrobial activities of Streptomyces isolates from mangrove sediment.
    J Basic Microbiol, 51(1): 71-9. [Abstract] [Full-text]
  166. Clinical features and outcomes of Staphylococcus aureus infections in non-neutropenic cancer patients.
    Support Care Cancer. [Abstract] [Full-text]
  167. Colonization and transmission of methicillin-susceptible and methicillin-resistant Staphylococcus aureus in a murine nasal colonization model.
    J Med Microbiol. [Abstract] [Full-text]
  168. Bacterial colonization patterns in neonates transferred from neonatal intensive care units.
    Int J Hyg Environ Health. [Abstract] [Full-text]
  169. Common Approaches to the Control of Multidrug-resistant Organisms Other Than Methicillin-resistant Staphylococcus aureus (MRSA).
    Infect Dis Clin North Am, 25(1): 181-200. [Abstract] [Full-text]
  170. Control of Methicillin-resistant Staphylococcus aureus.
    Infect Dis Clin North Am, 25(1): 155-79. [Abstract] [Full-text]
  171. Angioembolisation of pulmonary artery pseudoaneurysm arising in H1N1 influenza viral pneumonia.
    Heart Lung Circ. [Abstract] [Full-text]
  172. Ketamine inhibits tumor necrosis factor secretion by RAW264.7 murine macrophages stimulated with antibiotic-exposed strains of community-associated, methicillin-resistant Staphylococcus aureus.
    BMC Immunol, 12: 11. [Abstract] [Full-text]
  173. Host Chemokines Bind to Staphylococcus aureus and Stimulate Protein A Release.
    J Biol Chem, 286(7): 5069-77. [Abstract] [Full-text]
  174. Successful treatment of meticillin-resistant Staphylococcus aureus bacteraemia in a neonate using daptomycin.
    J Med Microbiol, 60: 381-3. [Abstract] [Full-text]
  175. Real-time evaluation of an optimized real-time PCR assay versus Brilliance chromogenic MRSA agar for the detection of meticillin-resistant Staphylococcus aureus from clinical specimens.
    J Med Microbiol, 60: 323-8. [Abstract] [Full-text]
  176. Drainage Surgery Followed by Postoperative Irrigation with Gentian Violet for Prosthetic Graft Infection Caused by Methicillin-resistant Staphylococcus aureus.
    Eur J Vasc Endovasc Surg, 41(2): 278-80. [Abstract] [Full-text]
  177. Phylogenetic analysis and antimicrobial activities of Streptomyces isolates from mangrove sediment.
    J Basic Microbiol, 51(1): 71-9. [Abstract] [Full-text]
  178. Simultaneous carriage of multiple genotypes of Staphylococcus aureus in children.
    J Med Microbiol, 60: 317-22. [Abstract] [Full-text]
  179. Knowledge, Awareness, and Attitudes Regarding Methicillin-Resistant Staphylococcus Aureus among Caregivers of Hospitalized Children.
    J Pediatr, 158(3): 416-21. [Abstract] [Full-text]
  180. Clinical features and outcomes of Staphylococcus aureus infections in non-neutropenic cancer patients.
    Support Care Cancer. [Abstract] [Full-text]
  181. Colonization and transmission of methicillin-susceptible and methicillin-resistant Staphylococcus aureus in a murine nasal colonization model.
    J Med Microbiol. [Abstract] [Full-text]
  182. Bacterial colonization patterns in neonates transferred from neonatal intensive care units.
    Int J Hyg Environ Health. [Abstract] [Full-text]
  183. Common approaches to the control of multidrug-resistant organisms other than methicillin-resistant Staphylococcus aureus (MRSA).
    Infect Dis Clin North Am, 25(1): 181-200. [Abstract] [Full-text]
  184. Control of methicillin-resistant Staphylococcus aureus.
    Infect Dis Clin North Am, 25(1): 155-79. [Abstract] [Full-text]
  185. Host chemokines bind to Staphylococcus aureus and stimulate protein A release.
    J Biol Chem, 286(7): 5069-77. [Abstract] [Full-text]
  186. Successful treatment of meticillin-resistant Staphylococcus aureus bacteraemia in a neonate using daptomycin.
    J Med Microbiol, 60: 381-3. [Abstract] [Full-text]
  187. Real-time evaluation of an optimized real-time PCR assay versus Brilliance chromogenic MRSA agar for the detection of meticillin-resistant Staphylococcus aureus from clinical specimens.
    J Med Microbiol, 60: 323-8. [Abstract] [Full-text]
  188. Simultaneous carriage of multiple genotypes of Staphylococcus aureus in children.
    J Med Microbiol, 60: 317-22. [Abstract] [Full-text]
  189. Knowledge, awareness, and attitudes regarding methicillin-resistant Staphylococcus aureus among caregivers of hospitalized children.
    J Pediatr, 158(3): 416-21. [Abstract] [Full-text]
  190. Common approaches to the control of multidrug-resistant organisms other than methicillin-resistant Staphylococcus aureus (MRSA).
    Infect Dis Clin North Am, 25(1): 181-200. [Abstract] [Full-text]
  191. Control of methicillin-resistant Staphylococcus aureus.
    Infect Dis Clin North Am, 25(1): 155-79. [Abstract] [Full-text]
  192. Successful treatment of meticillin-resistant Staphylococcus aureus bacteraemia in a neonate using daptomycin.
    J Med Microbiol, 60: 381-3. [Abstract] [Full-text]
  193. Real-time evaluation of an optimized real-time PCR assay versus Brilliance chromogenic MRSA agar for the detection of meticillin-resistant Staphylococcus aureus from clinical specimens.
    J Med Microbiol, 60: 323-8. [Abstract] [Full-text]
  194. Simultaneous carriage of multiple genotypes of Staphylococcus aureus in children.
    J Med Microbiol, 60: 317-22. [Abstract] [Full-text]
  195. Intraorbital and intracranial extension of sinusitis: comparative morbidity.
    J Pediatr, 158(3): 486-91. [Abstract] [Full-text]
  196. Knowledge, awareness, and attitudes regarding methicillin-resistant Staphylococcus aureus among caregivers of hospitalized children.
    J Pediatr, 158(3): 416-21. [Abstract] [Full-text]
  197. Impact of dose de-escalation and escalation on daptomycin'spharmacodynamics against clinical methicillin-resistant Staphylococcus aureus isolates in an in vitromodel.
    Antimicrob Agents Chemother. [Abstract] [Full-text]
  198. Microbiology and Antibiotic Management of Orbital Cellulitis.
    Pediatrics. [Abstract] [Full-text]
  199. Impact of dose de-escalation and escalation on daptomycin'spharmacodynamics against clinical methicillin-resistant Staphylococcus aureus isolates in an in vitromodel.
    Antimicrob Agents Chemother. [Abstract] [Full-text]
  200. Single-stage surgical treatment of infected nonunion of the distal tibia.
    J Orthop Trauma, 25(3): 156-61. [Abstract] [Full-text]
  201. The microbiological basis for a revised antibiotic regimen in high-energy tibial fractures: Preventing deep infections by nosocomial organisms.
    J Plast Reconstr Aesthet Surg, 64(3): 375-80. [Abstract] [Full-text]
  202. Impact of dose de-escalation and escalation on daptomycin'spharmacodynamics against clinical methicillin-resistant Staphylococcus aureus isolates in an in vitromodel.
    Antimicrob Agents Chemother. [Abstract] [Full-text]
  203. Single-stage surgical treatment of infected nonunion of the distal tibia.
    J Orthop Trauma, 25(3): 156-61. [Abstract] [Full-text]
  204. The microbiological basis for a revised antibiotic regimen in high-energy tibial fractures: preventing deep infections by nosocomial organisms.
    J Plast Reconstr Aesthet Surg, 64(3): 375-80. [Abstract] [Full-text]
  205. Single-stage surgical treatment of infected nonunion of the distal tibia.
    J Orthop Trauma, 25(3): 156-61. [Abstract] [Full-text]
  206. The microbiological basis for a revised antibiotic regimen in high-energy tibial fractures: preventing deep infections by nosocomial organisms.
    J Plast Reconstr Aesthet Surg, 64(3): 375-80. [Abstract] [Full-text]
  207. Dissemination of multiple MRSA clones among community-associated methicillin-resistant Staphylococcus aureus infections from Japanese children with impetigo.
    J Infect Chemother. [Abstract] [Full-text]
  208. Preoperative Biliary MRSA Infection in Patients Undergoing Hepatobiliary Resection with Cholangiojejunostomy: Incidence, Antibiotic Treatment, and Surgical Outcome.
    World J Surg. [Abstract] [Full-text]
  209. Healthcare-associated infections in rheumatology in Japan.
    Rheumatol Int. [Abstract] [Full-text]
  210. Genetic Variation in Spatio-Temporal Confined USA300 Community-Associated MRSA Isolates: A Shift from Clonal Dispersion to Genetic Evolution?
    PLoS One, 6(2): e16419. [Abstract] [Full-text]
  211. Proteome Analyses of Cellular Proteins in Methicillin-Resistant Staphylococcus aureus Treated with Rhodomyrtone, a Novel Antibiotic Candidate.
    PLoS One, 6(2): e16628. [Abstract] [Full-text]
  212. A new anti-MRSA antibiotic complex, WAP-8294A II. Structure characterization of minor components by ESI LCMS and MS/MS.
    J Antibiot (Tokyo). [Abstract] [Full-text]
  213. Transmission of Methicillin-resistant Staphylococcus aureus (MRSA) between Human and Hamster.
    J Clin Microbiol. [Abstract] [Full-text]
  214. Clinical and Laboratory Characteristics of Invasive Infections due to MRSA Isolates demonstrating Vancomycin MICs of 2 {mu}g/mL: Lack of Effect of hVISA Phenotype.
    J Clin Microbiol. [Abstract] [Full-text]
  215. SAR studies on dihydropyrimidinone antibiotics.
    Bioorg Med Chem Lett. [Abstract] [Full-text]
  216. Isolation and characterization of methicillin-resistant Staphylococcus aureus from fire stations in two northwest fire districts.
    Am J Infect Control. [Abstract] [Full-text]
  217. Bacteremia is an independent risk factor for mortality in nosocomial pneumonia: a prospective and observational multicentre study.
    Crit Care, 15(1): R62. [Abstract] [Full-text]
  218. A quantitative proteomic view on secreted, cell surface-associated and cytoplasmic proteins of the methicillin-resistant human pathogen Staphylococcus aureus under iron-limited conditions.
    J Proteome Res. [Abstract] [Full-text]
  219. Methicillin-resistant Staphylococcus-aureus-associated glomerulonephritis on the decline: decreased incidence since the 1990s.
    Clin Exp Nephrol, 15(1): 184-6. [Abstract] [Full-text]
  220. Hyperbaric oxygen therapy in a patient with autosomal dominant polycystic kidney disease with a perinephritic abscess.
    Clin Exp Nephrol, 15(1): 141-6. [Abstract] [Full-text]
  221. Dissemination of multiple MRSA clones among community-associated methicillin-resistant Staphylococcus aureus infections from Japanese children with impetigo.
    J Infect Chemother. [Abstract] [Full-text]
  222. Healthcare-associated infections in rheumatology in Japan.
    Rheumatol Int. [Abstract] [Full-text]
  223. Genetic Variation in Spatio-Temporal Confined USA300 Community-Associated MRSA Isolates: A Shift from Clonal Dispersion to Genetic Evolution?
    PLoS One, 6(2): e16419. [Abstract] [Full-text]
  224. Proteome Analyses of Cellular Proteins in Methicillin-Resistant Staphylococcus aureus Treated with Rhodomyrtone, a Novel Antibiotic Candidate.
    PLoS One, 6(2): e16628. [Abstract] [Full-text]
  225. A new anti-MRSA antibiotic complex, WAP-8294A II. Structure characterization of minor components by ESI LCMS and MS/MS.
    J Antibiot (Tokyo). [Abstract] [Full-text]
  226. Transmission of Methicillin-resistant Staphylococcus aureus (MRSA) between Human and Hamster.
    J Clin Microbiol. [Abstract] [Full-text]
  227. Clinical and Laboratory Characteristics of Invasive Infections due to MRSA Isolates demonstrating Vancomycin MICs of 2 {mu}g/mL: Lack of Effect of hVISA Phenotype.
    J Clin Microbiol. [Abstract] [Full-text]
  228. Isolation and characterization of methicillin-resistant Staphylococcus aureus from fire stations in two northwest fire districts.
    Am J Infect Control. [Abstract] [Full-text]
  229. Bacteremia is an independent risk factor for mortality in nosocomial pneumonia: a prospective and observational multicentre study.
    Crit Care, 15(1): R62. [Abstract] [Full-text]
  230. A quantitative proteomic view on secreted, cell surface-associated and cytoplasmic proteins of the methicillin-resistant human pathogen Staphylococcus aureus under iron-limited conditions.
    J Proteome Res. [Abstract] [Full-text]
  231. Methicillin-resistant Staphylococcus-aureus-associated glomerulonephritis on the decline: decreased incidence since the 1990s.
    Clin Exp Nephrol, 15(1): 184-6. [Abstract] [Full-text]
  232. Characteristics of Staphylococcus aureus colonization in patients with atopic dermatitis in Sri Lanka.
    Clin Exp Dermatol, 36(2): 195-200. [Abstract] [Full-text]
  233. Hyperbaric oxygen therapy in a patient with autosomal dominant polycystic kidney disease with a perinephritic abscess.
    Clin Exp Nephrol, 15(1): 141-6. [Abstract] [Full-text]
  234. Dissemination of multiple MRSA clones among community-associated methicillin-resistant Staphylococcus aureus infections from Japanese children with impetigo.
    J Infect Chemother. [Abstract] [Full-text]
  235. Healthcare-associated infections in rheumatology in Japan.
    Rheumatol Int. [Abstract] [Full-text]
  236. A new anti-MRSA antibiotic complex, WAP-8294A II. Structure characterization of minor components by ESI LCMS and MS/MS.
    J Antibiot (Tokyo). [Abstract] [Full-text]
  237. Transmission of Methicillin-resistant Staphylococcus aureus (MRSA) between Human and Hamster.
    J Clin Microbiol. [Abstract] [Full-text]
  238. Clinical and Laboratory Characteristics of Invasive Infections due to MRSA Isolates demonstrating Vancomycin MICs of 2 {mu}g/mL: Lack of Effect of hVISA Phenotype.
    J Clin Microbiol. [Abstract] [Full-text]
  239. Isolation and characterization of methicillin-resistant Staphylococcus aureus from fire stations in two northwest fire districts.
    Am J Infect Control. [Abstract] [Full-text]
  240. Characteristics of Staphylococcus aureus colonization in patients with atopic dermatitis in Sri Lanka.
    Clin Exp Dermatol, 36(2): 195-200. [Abstract] [Full-text]
  241. Characteristics of Staphylococcus aureus colonization in patients with atopic dermatitis in Sri Lanka.
    Clin Exp Dermatol, 36(2): 195-200. [Abstract] [Full-text]
  242. The rise and fall of MRSA infections in HIV patients.
    AIDS. [Abstract] [Full-text]
  243. The rise and fall of MRSA infections in HIV patients.
    AIDS. [Abstract] [Full-text]
  244. Essential Role for the Major Autolysin in the Fibronectin-Binding Protein-Mediated Staphylococcus aureus Biofilm Phenotype.
    Infect Immun, 79(3): 1153-65. [Abstract] [Full-text]
  245. The rise and fall of MRSA infections in HIV patients.
    AIDS. [Abstract] [Full-text]
  246. Essential role for the major autolysin in the fibronectin-binding protein-mediated Staphylococcus aureus biofilm phenotype.
    Infect Immun, 79(3): 1153-65. [Abstract] [Full-text]
  247. Essential role for the major autolysin in the fibronectin-binding protein-mediated Staphylococcus aureus biofilm phenotype.
    Infect Immun, 79(3): 1153-65. [Abstract] [Full-text]
  248. Epidemiology of borderline oxacillin-resistant Staphylococcus aureus in Pediatric Cystic Fibrosis.
    Pediatr Pulmonol. [Abstract] [Full-text]
  249. Mupirocin: biosynthesis, special features and applications of an antibiotic from a Gram-negative bacterium.
    Appl Microbiol Biotechnol. [Abstract] [Full-text]
  250. Prevalence, persistence, and microbiology of Staphylococcus aureus nasal carriage among hemodialysis outpatients at a major New York Hospital.
    Diagn Microbiol Infect Dis. [Abstract] [Full-text]
  251. Management of Gram-Positive Coccal Bacteremia and Hemodialysis.
    Am J Kidney Dis. [Abstract] [Full-text]
  252. Aerosol survival of Staphylococcus epidermidis.
    J Hosp Infect. [Abstract] [Full-text]
  253. Characterization of a mixed MRSA/MRSE biofilm in an explanted total ankle arthroplasty.
    FEMS Immunol Med Microbiol. [Abstract] [Full-text]
  254. Acute necrotic stomatitis (noma) associated with methicillin-resistant Staphylococcus aureus infection in a newly acquired rhesus macaque (Macaca mulatta).
    J Med Primatol. [Abstract] [Full-text]
  255. Prevalence of Staphylococcus aureus and antibiotic resistance in children with atopic dermatitis: A New Zealand experience.
    Australas J Dermatol, 52(1): 27-31. [Abstract] [Full-text]
  256. In vitro electrophysiological investigations of the acute effects of linezolid and novel oxazolidinones on central nervous system neurons.
    Neuroscience. [Abstract] [Full-text]
  257. In vitro antibacterial activity of ceftobiprole against clinical isolates from French teaching hospitals: proposition of zone diameter breakpoints.
    Int J Antimicrob Agents, 37(3): 235-9. [Abstract] [Full-text]
  258. The prevention of biofilm colonization by multidrug-resistant pathogens that cause ventilator-associated pneumonia with antimicrobial-coated endotracheal tubes.
    Biomaterials, 32(11): 2689-94. [Abstract] [Full-text]
  259. Tracing the transition of methicillin resistance in sub-populations of Staphylococcus aureus, using SELDI-TOF Mass Spectrometry and Artificial Neural Network Analysis.
    Syst Appl Microbiol, 34(1): 81-6. [Abstract] [Full-text]
  260. Rising incidence of Staphylococcus aureus with reduced susceptibility to vancomycin and susceptibility to antibiotics: a global analysis 2004-2009.
    Int J Antimicrob Agents, 37(3): 219-24. [Abstract] [Full-text]
  261. Epidemiology of borderline oxacillin-resistant Staphylococcus aureus in Pediatric Cystic Fibrosis.
    Pediatr Pulmonol. [Abstract] [Full-text]
  262. Mupirocin: biosynthesis, special features and applications of an antibiotic from a Gram-negative bacterium.
    Appl Microbiol Biotechnol. [Abstract] [Full-text]
  263. Prevalence, persistence, and microbiology of Staphylococcus aureus nasal carriage among hemodialysis outpatients at a major New York Hospital.
    Diagn Microbiol Infect Dis. [Abstract] [Full-text]
  264. Bacteremia in a multilevel geriatric hospital.
    J Am Med Dir Assoc, 12(3): 204-7. [Abstract] [Full-text]
  265. Management of Gram-Positive Coccal Bacteremia and Hemodialysis.
    Am J Kidney Dis. [Abstract] [Full-text]
  266. Aerosol survival of Staphylococcus epidermidis.
    J Hosp Infect. [Abstract] [Full-text]
  267. Characterization of a mixed MRSA/MRSE biofilm in an explanted total ankle arthroplasty.
    FEMS Immunol Med Microbiol. [Abstract] [Full-text]
  268. Acute necrotic stomatitis (noma) associated with methicillin-resistant Staphylococcus aureus infection in a newly acquired rhesus macaque (Macaca mulatta).
    J Med Primatol. [Abstract] [Full-text]
  269. Prevalence of Staphylococcus aureus and antibiotic resistance in children with atopic dermatitis: A New Zealand experience.
    Australas J Dermatol, 52(1): 27-31. [Abstract] [Full-text]
  270. Management of serious meticillin-resistant Staphylococcus aureus infections: what are the limits?
    Int J Antimicrob Agents, 37(3): 202-9. [Abstract] [Full-text]
  271. In vitro electrophysiological investigations of the acute effects of linezolid and novel oxazolidinones on central nervous system neurons.
    Neuroscience. [Abstract] [Full-text]
  272. In vitro antibacterial activity of ceftobiprole against clinical isolates from French teaching hospitals: proposition of zone diameter breakpoints.
    Int J Antimicrob Agents, 37(3): 235-9. [Abstract] [Full-text]
  273. The prevention of biofilm colonization by multidrug-resistant pathogens that cause ventilator-associated pneumonia with antimicrobial-coated endotracheal tubes.
    Biomaterials, 32(11): 2689-94. [Abstract] [Full-text]
  274. Tracing the transition of methicillin resistance in sub-populations of Staphylococcus aureus, using SELDI-TOF Mass Spectrometry and Artificial Neural Network Analysis.
    Syst Appl Microbiol, 34(1): 81-6. [Abstract] [Full-text]
  275. Rising incidence of Staphylococcus aureus with reduced susceptibility to vancomycin and susceptibility to antibiotics: a global analysis 2004-2009.
    Int J Antimicrob Agents, 37(3): 219-24. [Abstract] [Full-text]
  276. Genomic comparisons of USA300 Staphylococcus aureus colonizating the nose and rectum of children with skin abscesses.
    Microb Pathog, 50(3): 192-9. [Abstract] [Full-text]
  277. Meticillin-resistant Staphylococcus aureus (MRSA): screening and decolonisation.
    Int J Antimicrob Agents, 37(3): 195-201. [Abstract] [Full-text]
  278. Epidemiology of borderline oxacillin-resistant Staphylococcus aureus in Pediatric Cystic Fibrosis.
    Pediatr Pulmonol. [Abstract] [Full-text]
  279. Prevalence, persistence, and microbiology of Staphylococcus aureus nasal carriage among hemodialysis outpatients at a major New York Hospital.
    Diagn Microbiol Infect Dis. [Abstract] [Full-text]
  280. Bacteremia in a multilevel geriatric hospital.
    J Am Med Dir Assoc, 12(3): 204-7. [Abstract] [Full-text]
  281. Aerosol survival of Staphylococcus epidermidis.
    J Hosp Infect. [Abstract] [Full-text]
  282. Acute necrotic stomatitis (noma) associated with methicillin-resistant Staphylococcus aureus infection in a newly acquired rhesus macaque (Macaca mulatta).
    J Med Primatol. [Abstract] [Full-text]
  283. Management of serious meticillin-resistant Staphylococcus aureus infections: what are the limits?
    Int J Antimicrob Agents, 37(3): 202-9. [Abstract] [Full-text]
  284. In vitro antibacterial activity of ceftobiprole against clinical isolates from French teaching hospitals: proposition of zone diameter breakpoints.
    Int J Antimicrob Agents, 37(3): 235-9. [Abstract] [Full-text]
  285. Rising incidence of Staphylococcus aureus with reduced susceptibility to vancomycin and susceptibility to antibiotics: a global analysis 2004-2009.
    Int J Antimicrob Agents, 37(3): 219-24. [Abstract] [Full-text]
  286. Genomic comparisons of USA300 Staphylococcus aureus colonizating the nose and rectum of children with skin abscesses.
    Microb Pathog, 50(3): 192-9. [Abstract] [Full-text]
  287. Meticillin-resistant Staphylococcus aureus (MRSA): screening and decolonisation.
    Int J Antimicrob Agents, 37(3): 195-201. [Abstract] [Full-text]
  288. Isolation of culturable microorganisms from free-ranging bottlenose dolphins (Tursiops truncatus) from the southeastern United States.
    Vet Microbiol, 148(2): 440-7. [Abstract] [Full-text]
  289. Bacteremia in a multilevel geriatric hospital.
    J Am Med Dir Assoc, 12(3): 204-7. [Abstract] [Full-text]
  290. Management of serious meticillin-resistant Staphylococcus aureus infections: what are the limits?
    Int J Antimicrob Agents, 37(3): 202-9. [Abstract] [Full-text]
  291. In vitro antibacterial activity of ceftobiprole against clinical isolates from French teaching hospitals: proposition of zone diameter breakpoints.
    Int J Antimicrob Agents, 37(3): 235-9. [Abstract] [Full-text]
  292. The prevention of biofilm colonization by multidrug-resistant pathogens that cause ventilator-associated pneumonia with antimicrobial-coated endotracheal tubes.
    Biomaterials, 32(11): 2689-94. [Abstract] [Full-text]
  293. Rising incidence of Staphylococcus aureus with reduced susceptibility to vancomycin and susceptibility to antibiotics: a global analysis 2004-2009.
    Int J Antimicrob Agents, 37(3): 219-24. [Abstract] [Full-text]
  294. Genomic comparisons of USA300 Staphylococcus aureus colonizating the nose and rectum of children with skin abscesses.
    Microb Pathog, 50(3): 192-9. [Abstract] [Full-text]
  295. Meticillin-resistant Staphylococcus aureus (MRSA): screening and decolonisation.
    Int J Antimicrob Agents, 37(3): 195-201. [Abstract] [Full-text]
  296. Isolation of culturable microorganisms from free-ranging bottlenose dolphins (Tursiops truncatus) from the southeastern United States.
    Vet Microbiol, 148(2): 440-7. [Abstract] [Full-text]
  297. The prevention of biofilm colonization by multidrug-resistant pathogens that cause ventilator-associated pneumonia with antimicrobial-coated endotracheal tubes.
    Biomaterials, 32(11): 2689-94. [Abstract] [Full-text]
  298. Isolation of culturable microorganisms from free-ranging bottlenose dolphins (Tursiops truncatus) from the southeastern United States.
    Vet Microbiol, 148(2): 440-7. [Abstract] [Full-text]
  299. The prevention of biofilm colonization by multidrug-resistant pathogens that cause ventilator-associated pneumonia with antimicrobial-coated endotracheal tubes.
    Biomaterials, 32(11): 2689-94. [Abstract] [Full-text]
  300. Isolation of culturable microorganisms from free-ranging bottlenose dolphins (Tursiops truncatus) from the southeastern United States.
    Vet Microbiol, 148(2): 440-7. [Abstract] [Full-text]
  301. Chemical Constituents, Antimicrobial and Antimalarial Activities of Zanthoxylum monophyllum.
    Planta Med. [Abstract] [Full-text]
  302. Subcutaneous infection of methicillin resistant Staphylococcus aureus (MRSA).
    J Vis Exp. [Abstract] [Full-text]
  303. Randomized Controlled Trial of Cephalexin Versus Clindamycin for Uncomplicated Pediatric Skin Infections.
    Pediatrics. [Abstract] [Full-text]
  304. Maximizing the Therapeutic Window of an Antimicrobial Drug by Imparting Mitochondrial Sequestration in Human Cells.
    J Am Chem Soc. [Abstract] [Full-text]
  305. Prevalence and characteristics of methicillin-resistant coagulase-negative staphylococci from livestock, chicken carcasses, bulk tank milk, minced meat, and contact persons.
    BMC Vet Res, 7: 6. [Abstract] [Full-text]
  306. Chemical Constituents, Antimicrobial and Antimalarial Activities of Zanthoxylum monophyllum.
    Planta Med. [Abstract] [Full-text]
  307. Subcutaneous infection of methicillin resistant Staphylococcus aureus (MRSA).
    J Vis Exp. [Abstract] [Full-text]
  308. Maximizing the Therapeutic Window of an Antimicrobial Drug by Imparting Mitochondrial Sequestration in Human Cells.
    J Am Chem Soc. [Abstract] [Full-text]
  309. Prevalence and characteristics of methicillin-resistant coagulase-negative staphylococci from livestock, chicken carcasses, bulk tank milk, minced meat, and contact persons.
    BMC Vet Res, 7: 6. [Abstract] [Full-text]
  310. Chemical Constituents, Antimicrobial and Antimalarial Activities of Zanthoxylum monophyllum.
    Planta Med. [Abstract] [Full-text]
  311. Endogenous methicillin-resistant Staphylococcus aureus endophthalmitis.
    Retina, 31(3): 596-601. [Abstract] [Full-text]
  312. Efficacy of topical delivered Moxifloxacin against MRSA and Pseudomonas aeruginosa wound infection.
    Antimicrob Agents Chemother. [Abstract] [Full-text]
  313. Comparative Genome Sequencing of an Isogenic Pair of USA800 Clinical MRSA Isolates Obtained Before and After Daptomycin Treatment Failure.
    Antimicrob Agents Chemother. [Abstract] [Full-text]
  314. In vitro activity of fusidic acid (CEM-102, sodium fusidate) against Staphylococcus aureus isolated from cystic fibrosis patients and its effect on the activities of tobramycin and amikacin against Pseudomonas aeruginosa and Burkholderia cepacia.
    Antimicrob Agents Chemother. [Abstract] [Full-text]
  315. Characterization of a Novel Arginine Catabolic Mobile Element (ACME) and Staphylococcal Chromosomal Cassette mec Composite Island with Significant Homology to Staphylococcus epidermidis ACME type II in Methicillin-Resistant Staphylococcus aureus Genotype ST22-MRSA-IV.
    Antimicrob Agents Chemother. [Abstract] [Full-text]
  316. Successful treatment of a MRSA bacteremia and MRSA/VRE cholecystitis by daptomycin: a case report.
    Antimicrob Agents Chemother. [Abstract] [Full-text]
  317. Development and Initial Results of a Low Cost, Disposable, Point-of-Care Testing Device for Pathogen Detection.
    IEEE Trans Biomed Eng, 58(3): 805-8. [Abstract] [Full-text]
  318. Characterization of the 'pristinamycin supercluster' of Streptomyces pristinaespiralis.
    Microb Biotechnol, 4(2): 192-206. [Abstract] [Full-text]
  319. Influenza Virus Primes Mice for Pneumonia From Staphylococcus aureus.
    J Infect Dis, 203(6): 880-8. [Abstract] [Full-text]
  320. Endogenous methicillin-resistant Staphylococcus aureus endophthalmitis.
    Retina, 31(3): 596-601. [Abstract] [Full-text]
  321. Efficacy of topical delivered Moxifloxacin against MRSA and Pseudomonas aeruginosa wound infection.
    Antimicrob Agents Chemother. [Abstract] [Full-text]
  322. Comparative Genome Sequencing of an Isogenic Pair of USA800 Clinical MRSA Isolates Obtained Before and After Daptomycin Treatment Failure.
    Antimicrob Agents Chemother. [Abstract] [Full-text]
  323. In vitro activity of fusidic acid (CEM-102, sodium fusidate) against Staphylococcus aureus isolated from cystic fibrosis patients and its effect on the activities of tobramycin and amikacin against Pseudomonas aeruginosa and Burkholderia cepacia.
    Antimicrob Agents Chemother. [Abstract] [Full-text]
  324. Characterization of a Novel Arginine Catabolic Mobile Element (ACME) and Staphylococcal Chromosomal Cassette mec Composite Island with Significant Homology to Staphylococcus epidermidis ACME type II in Methicillin-Resistant Staphylococcus aureus Genotype ST22-MRSA-IV.
    Antimicrob Agents Chemother. [Abstract] [Full-text]
  325. Successful treatment of a MRSA bacteremia and MRSA/VRE cholecystitis by daptomycin: a case report.
    Antimicrob Agents Chemother. [Abstract] [Full-text]
  326. Development and Initial Results of a Low Cost, Disposable, Point-of-Care Testing Device for Pathogen Detection.
    IEEE Trans Biomed Eng, 58(3): 805-8. [Abstract] [Full-text]
  327. Characterization of the 'pristinamycin supercluster' of Streptomyces pristinaespiralis.
    Microb Biotechnol, 4(2): 192-206. [Abstract] [Full-text]
  328. Influenza Virus Primes Mice for Pneumonia From Staphylococcus aureus.
    J Infect Dis, 203(6): 880-8. [Abstract] [Full-text]
  329. Endogenous methicillin-resistant Staphylococcus aureus endophthalmitis.
    Retina, 31(3): 596-601. [Abstract] [Full-text]
  330. Development and initial results of a low cost, disposable, point-of-care testing device for pathogen detection.
    IEEE Trans Biomed Eng, 58(3): 805-8. [Abstract] [Full-text]
  331. Characterization of the 'pristinamycin supercluster' of Streptomyces pristinaespiralis.
    Microb Biotechnol, 4(2): 192-206. [Abstract] [Full-text]
  332. Influenza virus primes mice for pneumonia from Staphylococcus aureus.
    J Infect Dis, 203(6): 880-8. [Abstract] [Full-text]
  333. Influenza virus primes mice for pneumonia from Staphylococcus aureus.
    J Infect Dis, 203(6): 880-8. [Abstract] [Full-text]
  334. Public engagement with emerging infectious disease: The case of MRSA in Britain.
    Psychol Health. [Abstract] [Full-text]
  335. Persistence of Livestock Associated MRSA CC398 in Humans Is Dependent on Intensity of Animal Contact.
    PLoS One, 6(2): e16830. [Abstract] [Full-text]
  336. Small Molecule Inhibitors of Staphylococcus aureus RnpA Alter Cellular mRNA Turnover, Exhibit Antimicrobial Activity, and Attenuate Pathogenesis.
    PLoS Pathog, 7(2): e1001287. [Abstract] [Full-text]
  337. Evaluation of microbiological spectrum and risk factors of cellulitis in hospitalized patients.
    Cutan Ocul Toxicol. [Abstract] [Full-text]
  338. Bacterial Toxin-Triggered Drug Release from Gold Nanoparticle-Stabilized Liposomes for the Treatment of Bacterial Infection.
    J Am Chem Soc. [Abstract] [Full-text]
  339. Skin and soft-tissue infections in suburban primary care: epidemiology of methicillin-resistant Staphylococcus aureus and observations on abscess management.
    BMC Res Notes, 4(1): 33. [Abstract] [Full-text]
  340. Multiple splenic infarctions due to septic embolization in a patient supported with Berlin Heart-EXCOR biventricular assist device.
    Interact Cardiovasc Thorac Surg, 12(3): 497-9. [Abstract] [Full-text]
  341. Public engagement with emerging infectious disease: The case of MRSA in Britain.
    Psychol Health. [Abstract] [Full-text]
  342. Small Molecule Inhibitors of Staphylococcus aureus RnpA Alter Cellular mRNA Turnover, Exhibit Antimicrobial Activity, and Attenuate Pathogenesis.
    PLoS Pathog, 7(2): e1001287. [Abstract] [Full-text]
  343. Evaluation of microbiological spectrum and risk factors of cellulitis in hospitalized patients.
    Cutan Ocul Toxicol. [Abstract] [Full-text]
  344. Multiple splenic infarctions due to septic embolization in a patient supported with Berlin Heart-EXCOR biventricular assist device.
    Interact Cardiovasc Thorac Surg, 12(3): 497-9. [Abstract] [Full-text]
  345. Skin infections in HIV-infected individuals in the era of HAART.
    Curr Opin Infect Dis, 24(2): 124-9. [Abstract] [Full-text]
  346. Multiple splenic infarctions due to septic embolization in a patient supported with Berlin Heart-EXCOR biventricular assist device.
    Interact Cardiovasc Thorac Surg, 12(3): 497-9. [Abstract] [Full-text]
  347. The nosocomial transmission rate of animal-associated ST398 meticillin-resistant Staphylococcus aureus.
    J R Soc Interface, 8(57): 578-84. [Abstract] [Full-text]
  348. Skin infections in HIV-infected individuals in the era of HAART.
    Curr Opin Infect Dis, 24(2): 124-9. [Abstract] [Full-text]
  349. The nosocomial transmission rate of animal-associated ST398 meticillin-resistant Staphylococcus aureus.
    J R Soc Interface, 8(57): 578-84. [Abstract] [Full-text]
  350. Skin infections in HIV-infected individuals in the era of HAART.
    Curr Opin Infect Dis, 24(2): 124-9. [Abstract] [Full-text]
  351. The nosocomial transmission rate of animal-associated ST398 meticillin-resistant Staphylococcus aureus.
    J R Soc Interface, 8(57): 578-84. [Abstract] [Full-text]
  352. Effect of manuka honey on the expression of universal stress protein A in meticillin-resistant Staphylococcus aureus.
    Int J Antimicrob Agents. [Abstract] [Full-text]
  353. Prospective, Noncomparative Study of Daptomycin for the Treatment of Superficial and Deep Incisional Surgical Site Infections.
    Surg Infect (Larchmt). [Abstract] [Full-text]
  354. Experimental Osteomyelitis Caused by Methicillin-Resistant Staphylococcus aureus Treated with a Polylactide Carrier Releasing Linezolid.
    Surg Infect (Larchmt). [Abstract] [Full-text]
  355. Therapeutic Efficacy of Halocidin-Derived Peptide HG1 in a Mouse Model of Surgical Wound Infection with Methicillin-Resistant Staphylococcus aureus.
    Antimicrob Agents Chemother, 55(3): 1296-9. [Abstract] [Full-text]
  356. Dolabellanes with Antibacterial Activity from the Brown Alga Dilophus spiralis.
    J Nat Prod, 74(2): 213-22. [Abstract] [Full-text]
  357. Treatment with Linezolid or Vancomycin in Combination with Rifampin Is Effective in an Animal Model of Methicillin-Resistant Staphylococcus aureus Foreign Body Osteomyelitis.
    Antimicrob Agents Chemother, 55(3): 1182-6. [Abstract] [Full-text]
  358. Systematic review and meta-analysis of the effectiveness and safety of tigecycline for treatment of infectious disease.
    Antimicrob Agents Chemother, 55(3): 1162-72. [Abstract] [Full-text]
  359. Investigation of the Potential for Mutational Resistance to XF-73, Retapamulin, Mupirocin, Fusidic Acid, Daptomycin, and Vancomycin in Methicillin-Resistant Staphylococcus aureus Isolates during a 55-Passage Study.
    Antimicrob Agents Chemother, 55(3): 1177-81. [Abstract] [Full-text]
  360. Distribution of Fusidic Acid Resistance Determinants in Methicillin-Resistant Staphylococcus aureus.
    Antimicrob Agents Chemother, 55(3): 1173-6. [Abstract] [Full-text]
  361. Prospective, Noncomparative Study of Daptomycin for the Treatment of Superficial and Deep Incisional Surgical Site Infections.
    Surg Infect (Larchmt). [Abstract] [Full-text]
  362. Experimental Osteomyelitis Caused by Methicillin-Resistant Staphylococcus aureus Treated with a Polylactide Carrier Releasing Linezolid.
    Surg Infect (Larchmt). [Abstract] [Full-text]
  363. Therapeutic Efficacy of Halocidin-Derived Peptide HG1 in a Mouse Model of Surgical Wound Infection with Methicillin-Resistant Staphylococcus aureus.
    Antimicrob Agents Chemother, 55(3): 1296-9. [Abstract] [Full-text]
  364. Dolabellanes with Antibacterial Activity from the Brown Alga Dilophus spiralis.
    J Nat Prod, 74(2): 213-22. [Abstract] [Full-text]
  365. Treatment with Linezolid or Vancomycin in Combination with Rifampin Is Effective in an Animal Model of Methicillin-Resistant Staphylococcus aureus Foreign Body Osteomyelitis.
    Antimicrob Agents Chemother, 55(3): 1182-6. [Abstract] [Full-text]
  366. Systematic review and meta-analysis of the effectiveness and safety of tigecycline for treatment of infectious disease.
    Antimicrob Agents Chemother, 55(3): 1162-72. [Abstract] [Full-text]
  367. Investigation of the Potential for Mutational Resistance to XF-73, Retapamulin, Mupirocin, Fusidic Acid, Daptomycin, and Vancomycin in Methicillin-Resistant Staphylococcus aureus Isolates during a 55-Passage Study.
    Antimicrob Agents Chemother, 55(3): 1177-81. [Abstract] [Full-text]
  368. Distribution of Fusidic Acid Resistance Determinants in Methicillin-Resistant Staphylococcus aureus.
    Antimicrob Agents Chemother, 55(3): 1173-6. [Abstract] [Full-text]
  369. Therapeutic efficacy of halocidin-derived peptide HG1 in a mouse model of surgical wound infection with methicillin-resistant Staphylococcus aureus.
    Antimicrob Agents Chemother, 55(3): 1296-9. [Abstract] [Full-text]
  370. Dolabellanes with antibacterial activity from the brown alga Dilophus spiralis.
    J Nat Prod, 74(2): 213-22. [Abstract] [Full-text]
  371. Treatment with linezolid or vancomycin in combination with rifampin is effective in an animal model of methicillin-resistant Staphylococcus aureus foreign body osteomyelitis.
    Antimicrob Agents Chemother, 55(3): 1182-6. [Abstract] [Full-text]
  372. Systematic review and meta-analysis of the effectiveness and safety of tigecycline for treatment of infectious disease.
    Antimicrob Agents Chemother, 55(3): 1162-72. [Abstract] [Full-text]
  373. Investigation of the potential for mutational resistance to XF-73, retapamulin, mupirocin, fusidic acid, daptomycin, and vancomycin in methicillin-resistant Staphylococcus aureus isolates during a 55-passage study.
    Antimicrob Agents Chemother, 55(3): 1177-81. [Abstract] [Full-text]
  374. Distribution of fusidic acid resistance determinants in methicillin-resistant Staphylococcus aureus.
    Antimicrob Agents Chemother, 55(3): 1173-6. [Abstract] [Full-text]
  375. In vitro activity of ceftobiprole against frequently encountered aerobic and facultative Gram-positive and Gram-negative bacterial pathogens: results of the CANWARD 2007-2009 study.
    Diagn Microbiol Infect Dis, 69(3): 348-355. [Abstract] [Full-text]
  376. In vitro activity of dalbavancin and telavancin against staphylococci and streptococci isolated from patients in Canadian hospitals: results of the CANWARD 2007-2009 study.
    Diagn Microbiol Infect Dis, 69(3): 342-347. [Abstract] [Full-text]
  377. Comparison of community-associated and health care-associated methicillin-resistant Staphylococcus aureus in Canada: results of the CANWARD 2007-2009 study.
    Diagn Microbiol Infect Dis, 69(3): 320-325. [Abstract] [Full-text]
  378. Prevalence of antimicrobial resistant pathogens from blood cultures from Canadian hospitals: results of the CANWARD 2007-2009 study.
    Diagn Microbiol Infect Dis, 69(3): 307-313. [Abstract] [Full-text]
  379. Antimicrobial susceptibility of 15,644 pathogens from Canadian hospitals: results of the CANWARD 2007-2009 study.
    Diagn Microbiol Infect Dis, 69(3): 291-306. [Abstract] [Full-text]
  380. In vitro activity of telavancin and comparator antimicrobial agents against a panel of genetically defined staphylococci.
    Diagn Microbiol Infect Dis, 69(3): 275-9. [Abstract] [Full-text]
  381. Surveillance of methicillin-resistant Staphylococcus aureus isolated in Torino (northwest Italy).
    Diagn Microbiol Infect Dis, 69(3): 250-7. [Abstract] [Full-text]
  382. MRSA: a case of pathogens, politics and penalties.
    Trends Microbiol. [Abstract] [Full-text]
  383. Diffusion of meticillin-resistant Staphylococcus aureus USA300 strains in central Italy.
    Int J Antimicrob Agents. [Abstract] [Full-text]
  384. Microarray-based genotyping of Staphylococcus aureus isolates from camels.
    Vet Microbiol. [Abstract] [Full-text]
  385. Genetic relatedness of methicillin-resistant Staphylococcus pseudintermedius (MRSP) isolated from a dog and the dog owner.
    Res Vet Sci. [Abstract] [Full-text]
  386. Low risk despite high endemicity of methicillin-resistant Staphylococcus aureus infections following elective total joint arthroplasty: A 12-year experience.
    Ann Med. [Abstract] [Full-text]
  387. Assessment of phytochemical content, polyphenolic composition, antioxidant and antibacterial activities of Leguminosae medicinal plants in Peninsular Malaysia.
    BMC Complement Altern Med, 11(1): 12. [Abstract] [Full-text]
  388. Diversity of accessory genome of human and livestock-associated ST398 methicillin resistant Staphylococcus aureus strains.
    Infect Genet Evol, 11(2): 290-9. [Abstract] [Full-text]
  389. Gaseous and air decontamination technologies for Clostridium difficile in the healthcare environment.
    J Hosp Infect, 77(3): 199-203. [Abstract] [Full-text]
  390. Influence of ciprofloxacin and vancomycin on mutation rate and transposition of IS256 in Staphylococcus aureus.
    Int J Med Microbiol, 301(3): 229-36. [Abstract] [Full-text]
  391. Review of resistance of ocular isolates of Pseudomonas aeruginosa and staphylococci from keratitis to ciprofloxacin, gentamicin and cephalosporins.
    Clin Exp Optom, 94(2): 161-8. [Abstract] [Full-text]
  392. Catastrophic antiphospholipid syndrome in a community-acquired methicillin-resistant Staphylococcus aureus infection: A review of pathogenesis with a case for molecular mimicry.
    Autoimmun Rev, 10(4): 181-8. [Abstract] [Full-text]
  393. In vitro activity of ceftobiprole against frequently encountered aerobic and facultative Gram-positive and Gram-negative bacterial pathogens: results of the CANWARD 2007-2009 study.
    Diagn Microbiol Infect Dis, 69(3): 348-355. [Abstract] [Full-text]
  394. In vitro activity of dalbavancin and telavancin against staphylococci and streptococci isolated from patients in Canadian hospitals: results of the CANWARD 2007-2009 study.
    Diagn Microbiol Infect Dis, 69(3): 342-347. [Abstract] [Full-text]
  395. Comparison of community-associated and health care-associated methicillin-resistant Staphylococcus aureus in Canada: results of the CANWARD 2007-2009 study.
    Diagn Microbiol Infect Dis, 69(3): 320-325. [Abstract] [Full-text]
  396. Prevalence of antimicrobial resistant pathogens from blood cultures from Canadian hospitals: results of the CANWARD 2007-2009 study.
    Diagn Microbiol Infect Dis, 69(3): 307-313. [Abstract] [Full-text]
  397. Antimicrobial susceptibility of 15,644 pathogens from Canadian hospitals: results of the CANWARD 2007-2009 study.
    Diagn Microbiol Infect Dis, 69(3): 291-306. [Abstract] [Full-text]
  398. In vitro activity of telavancin and comparator antimicrobial agents against a panel of genetically defined staphylococci.
    Diagn Microbiol Infect Dis, 69(3): 275-9. [Abstract] [Full-text]
  399. Surveillance of methicillin-resistant Staphylococcus aureus isolated in Torino (northwest Italy).
    Diagn Microbiol Infect Dis, 69(3): 250-7. [Abstract] [Full-text]
  400. Microarray-based genotyping of Staphylococcus aureus isolates from camels.
    Vet Microbiol. [Abstract] [Full-text]
  401. Genetic relatedness of methicillin-resistant Staphylococcus pseudintermedius (MRSP) isolated from a dog and the dog owner.
    Res Vet Sci. [Abstract] [Full-text]
  402. Low risk despite high endemicity of methicillin-resistant Staphylococcus aureus infections following elective total joint arthroplasty: A 12-year experience.
    Ann Med. [Abstract] [Full-text]
  403. Assessment of phytochemical content, polyphenolic composition, antioxidant and antibacterial activities of Leguminosae medicinal plants in Peninsular Malaysia.
    BMC Complement Altern Med, 11: 12. [Abstract] [Full-text]
  404. Diversity of accessory genome of human and livestock-associated ST398 methicillin resistant Staphylococcus aureus strains.
    Infect Genet Evol, 11(2): 290-9. [Abstract] [Full-text]
  405. Gaseous and air decontamination technologies for Clostridium difficile in the healthcare environment.
    J Hosp Infect, 77(3): 199-203. [Abstract] [Full-text]
  406. Influence of ciprofloxacin and vancomycin on mutation rate and transposition of IS256 in Staphylococcus aureus.
    Int J Med Microbiol, 301(3): 229-36. [Abstract] [Full-text]
  407. Review of resistance of ocular isolates of Pseudomonas aeruginosa and staphylococci from keratitis to ciprofloxacin, gentamicin and cephalosporins.
    Clin Exp Optom, 94(2): 161-8. [Abstract] [Full-text]
  408. In vitro activity of ceftobiprole against frequently encountered aerobic and facultative Gram-positive and Gram-negative bacterial pathogens: results of the CANWARD 2007-2009 study.
    Diagn Microbiol Infect Dis, 69(3): 348-55. [Abstract] [Full-text]
  409. In vitro activity of dalbavancin and telavancin against staphylococci and streptococci isolated from patients in Canadian hospitals: results of the CANWARD 2007-2009 study.
    Diagn Microbiol Infect Dis, 69(3): 342-7. [Abstract] [Full-text]
  410. Comparison of community-associated and health care-associated methicillin-resistant Staphylococcus aureus in Canada: results of the CANWARD 2007-2009 study.
    Diagn Microbiol Infect Dis, 69(3): 320-5. [Abstract] [Full-text]
  411. Prevalence of antimicrobial resistant pathogens from blood cultures from Canadian hospitals: results of the CANWARD 2007-2009 study.
    Diagn Microbiol Infect Dis, 69(3): 307-13. [Abstract] [Full-text]
  412. Antimicrobial susceptibility of 15,644 pathogens from Canadian hospitals: results of the CANWARD 2007-2009 study.
    Diagn Microbiol Infect Dis, 69(3): 291-306. [Abstract] [Full-text]
  413. In vitro activity of telavancin and comparator antimicrobial agents against a panel of genetically defined staphylococci.
    Diagn Microbiol Infect Dis, 69(3): 275-9. [Abstract] [Full-text]
  414. Surveillance of methicillin-resistant Staphylococcus aureus isolated in Torino (northwest Italy).
    Diagn Microbiol Infect Dis, 69(3): 250-7. [Abstract] [Full-text]
  415. Diversity of accessory genome of human and livestock-associated ST398 methicillin resistant Staphylococcus aureus strains.
    Infect Genet Evol, 11(2): 290-9. [Abstract] [Full-text]
  416. Gaseous and air decontamination technologies for Clostridium difficile in the healthcare environment.
    J Hosp Infect, 77(3): 199-203. [Abstract] [Full-text]
  417. Influence of ciprofloxacin and vancomycin on mutation rate and transposition of IS256 in Staphylococcus aureus.
    Int J Med Microbiol, 301(3): 229-36. [Abstract] [Full-text]
  418. Review of resistance of ocular isolates of Pseudomonas aeruginosa and staphylococci from keratitis to ciprofloxacin, gentamicin and cephalosporins.
    Clin Exp Optom, 94(2): 161-8. [Abstract] [Full-text]
Place a permanent text-link or advertisement here.

© 2004-2012 MRSA Research Today. All Rights Reserved.



MRSA Research Today Archive:

Volume 1 (2004)
  Issue 1 (October)
  Issue 2 (November)
  Issue 3 (December)

Volume 2 (2005)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 3 (2006)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 4 (2007)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 5 (2008)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 6 (2009)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 7 (2010)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 8 (2011)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 9 (2012)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)



MRSA Books

License To Kill

License To Kill